Bleeding and Platelet Disorders
Gene: TBXA2R
Susceptibility to platelet-type bleeding disorder-13 is due to a defective thromboxane A2 receptor on platelets. The susceptibility is inherited in an autosomal dominant pattern, but clinical features, including mild mucocutaneous bleeding, occur only in the presence of a 'second hit' affecting platelet function; this second hit may be either in the TBXA2R gene or in another gene affecting the coagulation cascade. Amber rating as not clearly a Mendelian disorder.Created: 4 Jun 2021, 2 a.m. | Last Modified: 4 Jun 2021, 2 a.m.
Panel Version: 0.297
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
{Bleeding disorder, platelet-type, 13, susceptibility to}, MIM# 614009
Publications
Gene: tbxa2r has been classified as Amber List (Moderate Evidence).
Phenotypes for gene: TBXA2R were changed from to {Bleeding disorder, platelet-type, 13, susceptibility to}, MIM# 614009
Publications for gene: TBXA2R were set to
Mode of inheritance for gene: TBXA2R was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Gene: tbxa2r has been classified as Amber List (Moderate Evidence).
gene: TBXA2R was added gene: TBXA2R was added to Bleeding Disorders_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: TBXA2R was set to Unknown